Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy
Completed · Not applicable · Has a placebo group
Conditions studied: Calciphylaxis, Calcific Uremic Arteriolopathy
In brief
Calcific uremic arteriolopathy a.k.a. calciphylaxis is a vascular calcification disorder seen in dialysis patients. Calcific uremic arteriolopathy has 60-80% one-year mortality and significant morbidity associated with non-healing and extremely painful skin lesions. At present, there is no effective treatment for calcific uremic arteriolopathy. Vitamin K is an important vitamin for inhibiting vascular calcification. It is known to increase the circulating levels of carboxylated Matrix Gla Protein, a potent inhibitor of vascular calcification. However, the effects of vitamin K supplementation in patients with calcific uremic arteriolopathy are unknown. The purpose of this study is to conduct a pilot randomized controlled trial to examine the effects of oral vitamin K supplementation on circulating levels of anti-calcification factor (carboxylated Matrix Gla Protein) and clinical outcomes in patients with calcific uremic arteriolopathy.
Key facts
- Study ID
- NCT02278692
- Run by
- Massachusetts General Hospital
- People needed
- 26
- Starts
- 2015-03-01
- Expected to finish
- 2019-08-01
- Last updated by the study team
- 2019-09-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Calcific uremic arteriolopathy (a.k.a. calciphylaxis)
You may not qualify if…
- Warfarin discontinuation contra-indicated (e.g. mechanical heart valve)
- Prior allergic reaction to vitamin K
- Prior history of venous thromboembolism*
- Pregnancy and lactation
- (*Patients with prior history of thrombosis who are treated with non-warfarin anticoagulant agents (e.g. apixaban, enoxaparin, etc) will be considered for inclusion)
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.